Stephen Anderson
2009
In 2009, Stephen Anderson earned a total compensation of $355.8K as Former Chief Financial Officer at OncoGenex Pharmaceuticals, a 33% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $46,053 |
|---|---|
| Option Awards | $125,542 |
| Salary | $184,211 |
| Total | $355,806 |
Anderson received $184.2K in salary, accounting for 52% of the total pay in 2009.
Anderson also received $46.1K in non-equity incentive plan and $125.5K in option awards.
Rankings
In 2009, Stephen Anderson's compensation ranked 7,896th out of 9,885 executives tracked by ExecPay. In other words, Anderson earned more than 20.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,896 out of 9,885 | 20th |
Division Manufacturing | 2,949 out of 3,690 | 20th |
Major group Chemicals And Allied Products | 669 out of 866 | 23rd |
Industry group Drugs | 479 out of 638 | 25th |
Industry In Vitro and In Vivo Diagnostic Substances | 29 out of 44 | 34th |
Source: SEC filing on April 21, 2011.
Anderson's colleagues
We found two more compensation records of executives who worked with Stephen Anderson at OncoGenex Pharmaceuticals in 2009.